No. | Age | Gender | BSA (m2) | MSKCC risk | Metastatic sites | Prior therapy |
---|---|---|---|---|---|---|
1 | 70 | Female | 1.298 | Intermediate | Lung, Lymph nodes | None |
2 | 58 | Female | 1.446 | Favorable | Abdominal wall, Lung, liver | None |
3 | 56 | Male | 1.929 | Intermediate | Lung | Interferon |
4 | 79 | Male | 1.710 | Favorable | Pancreas, Contralateral kidney | None |
5 | 62 | Male | 1.893 | Favorable | Pleura | None |
6 | 64 | Male | 1.659 | Intermediate | Lung | None |